AVITA Medical, Inc. (AVH.AX)
AUD 2.87
(-3.69%)
AUD 2.87
(-3.69%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 | -26.66 Million USD | 22.94% |
| 2021 | -34.6 Million USD | -30.17% |
| 2020 | -26.58 Million USD | 36.75% |
| 2019 | -42.03 Million USD | -70.69% |
| 2018 | -24.62 Million AUD | -103.35% |
| 2017 | -12.1 Million AUD | -35.34% |
| 2016 | -8.94 Million AUD | -36.92% |
| 2015 | -6.53 Million AUD | -19.87% |
| 2014 | -5.45 Million AUD | -12.49% |
| 2013 | -4.84 Million AUD | 34.38% |
| 2012 | -7.38 Million AUD | 5.93% |
| 2011 | -7.85 Million AUD | -276.35% |
| 2010 | -2.08 Million AUD | 58.32% |
| 2009 | -5 Million AUD | -20.93% |
| 2008 | -4.13 Million AUD | 64.51% |
| 2007 | -11.66 Million AUD | 8.74% |
| 2006 | -12.77 Million AUD | -43.81% |
| 2005 | -8.88 Million AUD | 0.0% |
| 2003 | -4.98 Million AUD | -222.75% |
| 2002 | -1.54 Million AUD | -37.68% |
| 2001 | -1.12 Million AUD | 26.98% |
| 2000 | -1.53 Million AUD | -89.17% |
| 1999 | -812.05 Thousand AUD | -44.28% |
| 1998 | -562.84 Thousand AUD | 75.42% |
| 1997 | -2.28 Million AUD | -1341.54% |
| 1996 | 184.41 Thousand AUD | 114.35% |
| 1995 | -1.28 Million AUD | 33.66% |
| 1994 | -1.93 Million AUD | -759.14% |
| 1993 | -225.53 Thousand AUD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 Q2 | -10.38 Million USD | -12.62% |
| 2023 Q3 | -8.71 Million USD | 16.1% |
| 2023 Q1 | -9.22 Million USD | -72.24% |
| 2022 Q2 | -6.26 Million USD | 33.84% |
| 2022 Q4 | -5.35 Million USD | 4.21% |
| 2022 Q3 | -5.58 Million USD | 10.75% |
| 2022 Q1 | -9.46 Million USD | -11.61% |
| 2022 FY | -26.66 Million USD | 22.94% |
| 2021 FY | -34.6 Million USD | -30.17% |
| 2021 Q1 | -5.99 Million USD | -6.31% |
| 2021 Q2 | -4.71 Million USD | 21.33% |
| 2021 Q3 | -5.94 Million USD | -26.07% |
| 2021 Q4 | -8.47 Million USD | -42.55% |
| 2020 Q2 | -12.91 Million USD | 14.18% |
| 2020 FY | -26.58 Million USD | 36.75% |
| 2020 Q1 | -15.04 Million USD | -43.29% |
| 2020 Q3 | -10.22 Million USD | 20.81% |
| 2020 Q4 | -5.64 Million USD | 44.84% |
| 2019 Q1 | -9.88 Million USD | -26.94% |
| 2019 Q2 | -10 Million USD | -1.14% |
| 2019 Q4 | -10.5 Million USD | -194.5% |
| 2019 Q3 | -3.56 Million USD | 64.34% |
| 2019 FY | -42.03 Million USD | -70.69% |
| 2018 Q4 | -7.78 Million USD | 0.0% |
| 2018 FY | -24.62 Million AUD | -103.35% |
| 2018 Q3 | -7.78 Million USD | -46.17% |
| 2018 Q2 | -5.32 Million USD | -15.0% |
| 2018 Q1 | -4.63 Million USD | -27.83% |
| 2017 Q1 | -3.47 Million USD | -52.24% |
| 2017 Q4 | -3.62 Million USD | 0.0% |
| 2017 FY | -12.1 Million AUD | -35.34% |
| 2017 Q3 | -3.62 Million USD | -4.36% |
| 2017 Q2 | -3.47 Million USD | 0.0% |
| 2016 Q4 | -2.28 Million USD | 0.0% |
| 2016 FY | -8.94 Million AUD | -36.92% |
| 2016 Q2 | -2.54 Million USD | 0.0% |
| 2016 Q3 | -2.28 Million USD | 10.29% |
| 2016 Q1 | -2.54 Million USD | 1.89% |
| 2015 Q1 | -2.07 Million USD | -11.11% |
| 2015 Q2 | -2.07 Million USD | 0.0% |
| 2015 Q4 | -2.59 Million USD | 0.0% |
| 2015 Q3 | -2.59 Million USD | -25.24% |
| 2015 FY | -6.53 Million AUD | -19.87% |
| 2014 Q2 | -916.76 Thousand USD | 0.0% |
| 2014 FY | -5.45 Million AUD | -12.49% |
| 2014 Q4 | -1.86 Million USD | 0.0% |
| 2014 Q3 | -1.86 Million USD | -103.23% |
| 2014 Q1 | -916.76 Thousand USD | 44.67% |
| 2013 Q1 | -2.14 Million USD | -13.04% |
| 2013 FY | -4.84 Million AUD | 34.38% |
| 2013 Q4 | -1.65 Million USD | 0.0% |
| 2013 Q3 | -1.65 Million USD | 22.83% |
| 2013 Q2 | -2.14 Million USD | 0.0% |
| 2012 Q3 | -1.89 Million USD | 30.3% |
| 2012 Q1 | -2.72 Million USD | 0.0% |
| 2012 Q4 | -1.89 Million USD | 0.0% |
| 2012 Q2 | -2.72 Million USD | 0.0% |
| 2012 FY | -7.38 Million AUD | 5.93% |
| 2011 FY | -7.85 Million AUD | -276.35% |
| 2010 FY | -2.08 Million AUD | 58.32% |
| 2009 FY | -5 Million AUD | -20.93% |
| 2008 FY | -4.13 Million AUD | 64.51% |
| 2007 FY | -11.66 Million AUD | 8.74% |
| 2006 FY | -12.77 Million AUD | -43.81% |
| 2005 FY | -8.88 Million AUD | 0.0% |
| 2003 FY | -4.98 Million AUD | -222.75% |
| 2002 FY | -1.54 Million AUD | -37.68% |
| 2001 FY | -1.12 Million AUD | 26.98% |
| 2000 FY | -1.53 Million AUD | -89.17% |
| 1999 FY | -812.05 Thousand AUD | -44.28% |
| 1998 FY | -562.84 Thousand AUD | 75.42% |
| 1997 FY | -2.28 Million AUD | -1341.54% |
| 1996 FY | 184.41 Thousand AUD | 114.35% |
| 1995 FY | -1.28 Million AUD | 33.66% |
| 1994 FY | -1.93 Million AUD | -759.14% |
| 1993 FY | -225.53 Thousand AUD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| 4DMedical Limited | -35.97 Million AUD | 25.887% |
| Adherium Limited | -10.22 Million AUD | -160.803% |
| Aroa Biosurgery Limited | -9.74 Million AUD | -173.536% |
| Atomo Diagnostics Limited | -6.84 Million AUD | -289.395% |
| Anteris Technologies Ltd | -67.33 Million AUD | 60.399% |
| Control Bionics Limited | -5.91 Million AUD | -350.896% |
| CardieX Limited | -6.76 Million AUD | -294.14% |
| Compumedics Limited | -338 Thousand AUD | -7789.053% |
| Cochlear Limited | 356.8 Million AUD | 107.473% |
| CleanSpace Holdings Limited | -3.12 Million AUD | -752.696% |
| Cyclopharm Limited | -4.7 Million AUD | -467.243% |
| EMVision Medical Devices Ltd | -2.72 Million AUD | -876.879% |
| Nova Eye Medical Limited | -8.79 Million AUD | -203.356% |
| HeraMED Limited | -6.78 Million AUD | -293.076% |
| Imricor Medical Systems, Inc. | -22.62 Million AUD | -17.852% |
| ImpediMed Limited | -19.79 Million AUD | -34.74% |
| InhaleRx Limited | -1.44 Million AUD | -1747.539% |
| LBT Innovations Limited | -3.74 Million AUD | -612.968% |
| Micro-X Limited | -9.76 Million AUD | -173.067% |
| Neurotech International Limited | -5.06 Million AUD | -426.015% |
| OncoSil Medical Limited | -11.91 Million AUD | -123.819% |
| PolyNovo Limited | 5.26 Million AUD | 606.843% |
| Respiri Limited | -7.12 Million AUD | -274.023% |
| SomnoMed Limited | -12.24 Million AUD | -117.821% |
| Universal Biosensors, Inc. | -6.74 Million AUD | -295.531% |
| Uscom Limited | -2.07 Million AUD | -1185.216% |
| Visioneering Technologies, Inc. | -5.06 Million AUD | -426.632% |